(Q34301607)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

title

Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

Dopamine dysregulation syndrome

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Kelly D Foote

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Nikolaus R McFarland

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Michael S. Okun

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1

Ashok Sriram

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

4

Sanjay Iyer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Herbert E Ward

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Ramon L Rodriguez

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

25 September 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

260

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

521-527

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

9 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Impulsive and compulsive behaviors in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Drug-induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Valproic acid-induced parkinsonism in the elderly: a comprehensive review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Managing pathological gambling in Parkinson's disease with enteral levodopa/carbidopa infusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Addiction in Parkinson's disease: impact of subthalamic nucleus deep brain stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Dopamine dysregulation syndrome after deep brain stimulation of the subthalamic nucleus in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Valproate: a simple chemical with so much to offer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Migraine prophylaxis with divalproex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Valproic acid augments GABA-mediated postsynaptic inhibition in cultured mammalian neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Valproic acid inhibits the depolarizing rectification in neurons of rat amygdala.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Effects of antiepileptic drugs, calcium channel blockers and other compounds on seizures induced by activation of voltage-dependent L calcium channel in DBA/2 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

S-2-pentyl-4-pentynoic hydroxamic acid and its metabolite s-2-pentyl-4-pentynoic acid in the NMRI-exencephaly-mouse model: pharmacokinetic profiles, teratogenic effects, and histone deacetylase inhibition abilities of further valproic acid hydroxama

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

The anticonvulsant response to valproate in kindled rats is correlated with its effect on neuronal firing in the substantia nigra pars reticulata: a new mechanism of pharmacoresistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Bipolar disorder and mechanisms of action of mood stabilizers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Chronic valproate treatment blocks D2-like receptor-mediated brain signaling via arachidonic acid in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Epigenetic GABAergic targets in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Compulsive drug use linked to sensitized ventral striatal dopamine transmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Compulsive use of dopaminergic drug therapy in Parkinson's disease: reward and anti-reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Impulse control disorders in Parkinson disease: a multicenter case--control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Dopamine agonists and risk: impulse control disorders in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Dopamine dysregulation syndrome in Parkinson's disease: case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6669-1

Effect of inhibitors of GABA transaminase on the synthesis, binding, uptake, and metabolism of GABA

21 January 2018

1 reference

12 December 2020

Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture

1 reference

12 December 2020

Addiction-like manifestations and Parkinson's disease: a large single center 9-year experience

1 reference

12 December 2020

Dopamine agonists and pathologic behaviors

1 reference

12 December 2020

Dopaminergic dysregulation syndrome in Parkinson's disease

1 reference

12 December 2020

The evolution and origin of motor complications in Parkinson's disease

1 reference

12 December 2020

The natural history of Parkinson's disease in the pre-levodopa and post-levodopa eras

1 reference

12 December 2020

10.1007/S00415-012-6669-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

9 March 2020

1032959460

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23007193%20AND%20SRC:MED&resulttype=core&format=json